[go: up one dir, main page]

MA29934B1 - Traitement des symptomes de l'irritation vesicale - Google Patents

Traitement des symptomes de l'irritation vesicale

Info

Publication number
MA29934B1
MA29934B1 MA30903A MA30903A MA29934B1 MA 29934 B1 MA29934 B1 MA 29934B1 MA 30903 A MA30903 A MA 30903A MA 30903 A MA30903 A MA 30903A MA 29934 B1 MA29934 B1 MA 29934B1
Authority
MA
Morocco
Prior art keywords
irritation
symptoms
treatment
vesic
vesicular
Prior art date
Application number
MA30903A
Other languages
English (en)
Inventor
Hugues Bienayme
Jacques Ferte
Original Assignee
Urogene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogene filed Critical Urogene
Publication of MA29934B1 publication Critical patent/MA29934B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'INVENTION CONCERNE L'UTILISATION D'UN COMPOSÉ DE FORMULE (I) AUX FINS D'OBTENTION D'UN PRODUIT MÉDICINAL À UTILISER DANS LE TRAITEMENT DES SYMPTÔMES DE L'IRRITATION VÉSICALE.
MA30903A 2005-10-19 2008-05-05 Traitement des symptomes de l'irritation vesicale MA29934B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72783005P 2005-10-19 2005-10-19
FR0510650A FR2892022B1 (fr) 2005-10-19 2005-10-19 Traitement des symptomes de l'irritation de la vessie

Publications (1)

Publication Number Publication Date
MA29934B1 true MA29934B1 (fr) 2008-11-03

Family

ID=36579110

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30903A MA29934B1 (fr) 2005-10-19 2008-05-05 Traitement des symptomes de l'irritation vesicale

Country Status (15)

Country Link
US (1) US20080293774A1 (fr)
EP (1) EP1948175A1 (fr)
JP (1) JP2009512679A (fr)
KR (1) KR20080058451A (fr)
CN (1) CN101291674A (fr)
AU (1) AU2006305645A1 (fr)
BR (1) BRPI0617625A2 (fr)
CA (1) CA2626573A1 (fr)
FR (1) FR2892022B1 (fr)
IL (1) IL190800A0 (fr)
MA (1) MA29934B1 (fr)
NO (1) NO20082279L (fr)
RU (1) RU2008114395A (fr)
WO (1) WO2007046004A1 (fr)
ZA (1) ZA200803240B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions

Also Published As

Publication number Publication date
FR2892022A1 (fr) 2007-04-20
ZA200803240B (en) 2009-01-28
CN101291674A (zh) 2008-10-22
AU2006305645A1 (en) 2007-04-26
FR2892022B1 (fr) 2008-01-04
JP2009512679A (ja) 2009-03-26
EP1948175A1 (fr) 2008-07-30
IL190800A0 (en) 2008-12-29
RU2008114395A (ru) 2009-11-27
US20080293774A1 (en) 2008-11-27
BRPI0617625A2 (pt) 2011-08-02
KR20080058451A (ko) 2008-06-25
NO20082279L (no) 2008-05-19
WO2007046004A1 (fr) 2007-04-26
CA2626573A1 (fr) 2007-04-26

Similar Documents

Publication Publication Date Title
MA31710B1 (fr) (carboxylalkylenephenyl)phényloxamides, procédés pour la production de ceux-ci et utilisation de ceux-ci en tant que medicament
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
MA32904B1 (fr) Composes de purine
MA29377B1 (fr) Derives de la pyrimidine pour traitement de troubles a caractere hyperproliferatif
CY1110900T1 (el) Χημικες ενωσεις
CY1108275T1 (el) Χημικες ενωσεις
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
MA33076B1 (fr) Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer
MA32007B1 (fr) Azolylmethyloxiranes, leur utilisation et agents les contenant
MA31979B1 (fr) (cyclopropylphenyl) phenyloxamides, leur procede de production et leur utilisation comme medicament
DE602004007808D1 (de) Neue gamma secretase inhibitoren
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
MA30351B1 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TNSN04164A1 (fr) Inhibiteurs de acc.
MA31894B1 (fr) Composes organiques
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
MA34361B1 (fr) Dérivés de tétrahydro-pyrido-pyrimidine
MA30609B1 (fr) Imidazolidine-2,4-diones arylaminoaryl-alkyl-substituees, leur procede de synthese, les medicaments comprenant ces composes, et leurs applications.
ATE409480T1 (de) Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
DE602004008474D1 (de) N-sulfonylheterocyclopyrrolylalkylamin verbindungen als 5-hydroxytryptamin-6 liganden.
MA29934B1 (fr) Traitement des symptomes de l'irritation vesicale
EA200701856A1 (ru) Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении
DK1853241T3 (da) Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyclohexandion ved behandling af Parkinson's sygdom